ATE502T1 - SALTS OF NON-TOXIC ACTIVATED ANION EXCHANGE RESINS WITH 2-(4'-(P-CHLOROBENZOYL)-PH ENOXY)-2-(METHYL)-PROPIONIC ACID, CAPABLE OF PERMANENT BINDING TO BILATE ACIDS, AND PHARMACEUTICALS CONTAINING THESE SALTS. - Google Patents

SALTS OF NON-TOXIC ACTIVATED ANION EXCHANGE RESINS WITH 2-(4'-(P-CHLOROBENZOYL)-PH ENOXY)-2-(METHYL)-PROPIONIC ACID, CAPABLE OF PERMANENT BINDING TO BILATE ACIDS, AND PHARMACEUTICALS CONTAINING THESE SALTS.

Info

Publication number
ATE502T1
ATE502T1 AT79104010T AT79104010T ATE502T1 AT E502 T1 ATE502 T1 AT E502T1 AT 79104010 T AT79104010 T AT 79104010T AT 79104010 T AT79104010 T AT 79104010T AT E502 T1 ATE502 T1 AT E502T1
Authority
AT
Austria
Prior art keywords
salts
group
chlorobenzoyl
resins
acids
Prior art date
Application number
AT79104010T
Other languages
German (de)
Inventor
Valerio Dr. Borzatta
Manlio Dr. Cristofori
Angelo Dr. Brazzi
Original Assignee
Alfa Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici S.P.A. filed Critical Alfa Farmaceutici S.P.A.
Application granted granted Critical
Publication of ATE502T1 publication Critical patent/ATE502T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/05—Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur
    • C08B15/06—Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur containing nitrogen, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Phenolic Resins Or Amino Resins (AREA)

Abstract

A non-toxic anionic resin selected from resins having a polymeric reticulated skeleton of styrenic or acrylic type, inert to the digestive enzymes, having a molecular weight higher than 1000 and containing ionizable amino groups, resins having a cellulosic reticulated skeleton modified by the introduction of free or substituted amino groups and resins having a polysaccharide reticulated skeleton modified by the introduction of free or substituted amino groups. The resin is capable of binding itself permanently to the biliary acids and is salified with an acid corresponding to the general formula: <IMAGE> wherein: R' represents a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, a hydroxyalkyl group having 1 to 3 carbon atoms, R represents a chlorine atom or a group selected from p-chlorobenzoyl, p-bromobenzoyl and p-fluorobenzoyl, W represents a group selected from OH, -N(R''')-CH(R'')-(CH2)n-COOH and O-CH2-COOH wherein n represents a number from 0 to 5, R'' represents a hydrogen atom, a benzyl, a phenyl or a phenyl substituted with an OH group, a lower alkyl, a lower alkoxyl or a lower hydroxyalkyl group and R''' represents a hydrogen atom or a lower alkyl.
AT79104010T 1978-12-21 1979-10-17 SALTS OF NON-TOXIC ACTIVATED ANION EXCHANGE RESINS WITH 2-(4'-(P-CHLOROBENZOYL)-PH ENOXY)-2-(METHYL)-PROPIONIC ACID, CAPABLE OF PERMANENT BINDING TO BILATE ACIDS, AND PHARMACEUTICALS CONTAINING THESE SALTS. ATE502T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT03631/78A IT1106718B (en) 1978-12-21 1978-12-21 PHARMACOLOGICALLY ACTIVE SALONIZED ANIONIC RESIN BASED COMPOSITIONS
EP79104010A EP0012804B2 (en) 1978-12-21 1979-10-17 Salts of a non toxic, activated anion exchange resin capable of establishing a stable binding with bile acids and 2-(4'-(p-chlorobenzoyl)-phenoxy)-2-(methyl)-propionic acid and pharmaceutical compositions comprising these salts

Publications (1)

Publication Number Publication Date
ATE502T1 true ATE502T1 (en) 1982-01-15

Family

ID=11110905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79104010T ATE502T1 (en) 1978-12-21 1979-10-17 SALTS OF NON-TOXIC ACTIVATED ANION EXCHANGE RESINS WITH 2-(4'-(P-CHLOROBENZOYL)-PH ENOXY)-2-(METHYL)-PROPIONIC ACID, CAPABLE OF PERMANENT BINDING TO BILATE ACIDS, AND PHARMACEUTICALS CONTAINING THESE SALTS.

Country Status (11)

Country Link
US (1) US4340585A (en)
EP (1) EP0012804B2 (en)
JP (1) JPS55115403A (en)
AT (1) ATE502T1 (en)
DE (1) DE2961714D1 (en)
DK (1) DK159660C (en)
ES (1) ES487019A1 (en)
GR (1) GR72734B (en)
IT (1) IT1106718B (en)
NO (1) NO794225L (en)
YU (1) YU313079A (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393145A (en) * 1979-05-01 1983-07-12 Etablissement Texcontor Anionic ion exchange resins with cholesterol-decreasing properties
CH655507B (en) * 1983-01-12 1986-04-30
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
IT1190349B (en) * 1986-06-16 1988-02-16 Prodotti Formenti Srl PHARMACEUTICAL COMPOSITIONS WITH SEQUESTRANT ACTIVITY OF BILE ACIDS CONTAINING COLESTYRAMINE AS THE ACTIVE INGREDIENT, AND PROCEDURE TO PREPARE THEM
US4877775A (en) * 1986-06-16 1989-10-31 E. I. Du Pont De Nemours And Company Polymeric aminosaccharides as antihypercholesterolemic agents
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
US5498678A (en) * 1992-12-21 1996-03-12 Rohm And Haas Company Suspension polymerization process for water-soluble monomers
US5900475A (en) * 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US6129910A (en) * 1993-06-02 2000-10-10 Geltex Pharmaceuticals, Inc. Water-insoluble noncrosslinked bile acid sequestrants
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US5753262A (en) * 1995-06-07 1998-05-19 Aronex Pharmaceuticals, Inc. Cationic lipid acid salt of 3beta N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US6423754B1 (en) * 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
EP1572190B1 (en) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
PL3400944T3 (en) 2010-11-04 2020-11-16 Albireo Ab Ibat inhibitors for the treatment of liver diseases
PT2637646T (en) 2010-11-08 2016-08-17 Albireo Ab A PHARMACEUTICAL COMBINATION COMPREHENSING AN IBAT INHIBITOR AND A BILIARY ACID SEQUEROR
US20140323412A1 (en) 2011-10-28 2014-10-30 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
SG10201909122QA (en) 2011-10-28 2019-11-28 Lumena Pharmaceuticals Inc Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
CA2907214A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
CA2907230A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
JP7562546B2 (en) 2019-02-12 2024-10-07 ミルム ファーマシューティカルズ インコーポレイテッド Methods for increasing growth in pediatric subjects with cholestatic liver disease - Patents.com

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857194A (en) * 1957-07-05 1960-12-29 Clinical Products Ltd Therapeutic agents comprising ion-exchange resins
BE580490A (en) 1958-07-15 1960-01-08 Merck & Co Inc Compositions and methods for lowering the cholesterol content of the blood
FR4933M (en) * 1964-09-17 1967-03-28
NL7017227A (en) 1969-12-27 1971-06-29
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol

Also Published As

Publication number Publication date
DE2961714D1 (en) 1982-02-18
IT7803631A0 (en) 1978-12-21
EP0012804A1 (en) 1980-07-09
NO794225L (en) 1980-06-24
YU313079A (en) 1983-02-28
IT1106718B (en) 1985-11-18
US4340585A (en) 1982-07-20
GR72734B (en) 1983-12-01
EP0012804B1 (en) 1981-12-30
JPS6327362B2 (en) 1988-06-02
JPS55115403A (en) 1980-09-05
EP0012804B2 (en) 1987-03-04
ES487019A1 (en) 1980-10-01
DK159660C (en) 1991-04-08
DK548279A (en) 1980-06-22
DK159660B (en) 1990-11-12

Similar Documents

Publication Publication Date Title
ATE502T1 (en) SALTS OF NON-TOXIC ACTIVATED ANION EXCHANGE RESINS WITH 2-(4&#39;-(P-CHLOROBENZOYL)-PH ENOXY)-2-(METHYL)-PROPIONIC ACID, CAPABLE OF PERMANENT BINDING TO BILATE ACIDS, AND PHARMACEUTICALS CONTAINING THESE SALTS.
ES2164152T3 (en) COMPOSITION CONTAINING A RETICULATED POLYMER TO REMOVE BILIARY SALTS FROM A PATIENT.
GB2255339A (en) Peptidyl derivatives
LU91587I2 (en) Agomelatine and its pharmaceutically acceptable derivatives (VALDOXAN)
ES2149537T3 (en) INTERCHANGE RESIN OF UNLINKED ANIONS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME.
ES8604545A1 (en) Phenylacetic-acid derivatives, medicines containing these compounds and process for their preparation.
JPS5754107A (en)
ATE25078T1 (en) 2-AMINO-3-ACYLAMINO-6-BENZYLAMINO-PYRIDINE DERIVATIVES WITH ANTI-EPILEPTIC ACTIVITY.
PT69823A (en) 2- (2-ALKOXYETHYL) -2&#39;-HYDROXY-6,7-BENZOMORPHANES OF THE ACIDIC ACID SALT THEREOF AND THE METHOD FOR THE PRODUCTION THEREOF
SE8205698L (en) N- (4- (3-AMINOPROPYL) AMINOBUTYL-2- (OMEGA-GUANIDINOFETIC ACID-AMIDO) -2-SUBSTITUTED ETHANAMIDE, SALTS THEREOF AND PROCEDURE FOR PREPARING THEREOF
BR8202861A (en) COMPOUND COMPOSITION PHARMACEUTICAL PROCESS TO LOWER THE BLOOD PRESSURE OF HUMAN BEINGS PROCESS TO PREPARE A COMPOUND AND PROCESS TO PREPARE A PHARMACEUTICAL COMPOSITION
ES482002A1 (en) 5-Phenyl-pyrazole derivatives and their salts, processes for their preparation and medicines containing them.
ES543786A0 (en) PROCEDURE FOR THE PREPARATION OF NEW A-ETILBEN-ZOL DERIVATIVES WITH A SUBSTITUTED DIETHYLAMINOALCOXY GROUP AND ITS ADDITIONAL SALTS ACIDIC AND QUATERNARY AMMONICS
ATE49955T1 (en) SUBSTITUTED DERIVATIVES OF N|THYL(METH)ACRYLAMIDE, AND PROCESS FOR THEIR PREPARATION.
DK67384D0 (en) N-IMINOPYRIDINIUM BETAIN DERIVATIVES
DK0387489T3 (en) Use of 2,2,6,6-tetramethyl-4-aminopiperidinamides as fungicides
DK0818437T3 (en) Process for preparing aqueous solutions of unsaturated quaternary ammonium salts
ES488387A1 (en) Condensed derivatives of pyrrolidine or piperidine, process for their preparation and composition containing them.
ZA84571B (en) Compounds derived from amides of mercaptoacetic acid and from 3-mercaptopropionic acid and pharmaceutical compositions containing them
ATE120179T1 (en) METHOD FOR PRODUCING ALPHA-FLUORINATED ACRYLATES.
GB1261004A (en) Ketones derived from -1-(2-hydroxyethyl)-piperazine
GB1477937A (en) Aminals of aromatic aldehydes
ATE60048T1 (en) AMINO COMPOUNDS AND FUNGICIDES CONTAINING THEM.
ES8307253A1 (en) Dioxazabicyclic derivatives
ES8500885A1 (en) Compounds having calcium blocking activity

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee